Thursday, November 15, 2012

OVERCHARGING SET TO COST PHARMA COMPANIES FULL SALES REVENUE OF DRUG

A drug maker found overcharging will have to shell out the entire sales revenue of the medicine
from the date of its launch as penalty. National Pharmaceutical Pricing Authority (NPPA)
said that if a company has not been booked for overcharging for selling the product without price
approval, if any, pertaining to the period prior to fixation of the price of the said formulation, the
entire sale amount from the date of introduction of the product till issue of the price notification
order shall be recovered from the company, treating the entire sale proceeds as 'unauthorized
sales.

0 comments:

Post a comment